Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

R-2487 in Patients With Sjogren's Syndrome (SS)

Study ID: NCT06297213
Start Date: 2026-06-01
End Date: 2028-08-30
Study Type

Interventional

Study Phase

Phase1

No. of Participants

36

Intervention / Treatment

R-2487

Sponsor

Rise Therapeutics LLC

Source: clinicaltrials.gov

Share:
Add to list

Assessment of Acute Respiratory Distress in Children Presenting to the Emergency Department: Clinical, Epidemiological, and Etiological Insights

Study ID: NCT07149389
Start Date: 2026-08-30
End Date: 2027-12-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

70

Intervention / Treatment
Sponsor

Assiut University

Source: clinicaltrials.gov

Share:
Add to list

Postoperative Oral Tranexamic Acid in Patients Undergoing Primary Total Joint Arthroplasty

Study ID: NCT06832878
Start Date: 2026-06-01
End Date: 2026-06
Study Type

Interventional

Study Phase

Phase4

No. of Participants

101

Intervention / Treatment

Oral Tranexamic Acid

Sponsor

Mayo Clinic

Source: clinicaltrials.gov

Share:
Add to list

Clinical Trial of TB511 in Advanced Solid Tumors

Study ID: NCT06400160
Start Date: 2026-03
End Date: 2028-03
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

TB511

Caitrida

Sponsor

Twinpig Biolab, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Adebrelimab Maintenance Therapy for LS-SCLC Post Induction Chemo-Adebrelimab Plus CRT or CRT Alone

Study ID: NCT07381543
Start Date: 2026-03
End Date: 2028-08
Study Type

Interventional

Study Phase

Phase2

No. of Participants

76

Intervention / Treatment

Arm A

Arm B

Sponsor

Peking University Cancer Hospital & Institute

Source: clinicaltrials.gov

Share:
Add to list

Testing the Use of an IDH1 Inhibitor, Olutasidenib, in Acute Myeloid Leukemia Added to ASTX727 and Venetoclax; in High-Risk MDS Added to ASTX727; and Alone in Low Risk MDS (A MyeloMATCH Treatment Substudy)

Study ID: NCT07153497
Start Date: 2026-05-27
End Date: 2030-04-26
Study Type

Interventional

Study Phase

Phase2

No. of Participants

132

Intervention / Treatment

Biospecimen Collection

Bone Marrow Aspiration

Bone Marrow Biopsy

Decitabine and Cedazuridine

Olutasidenib

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

Study ID: NCT06953778
Start Date: 2026-06-01
End Date: 2033-10-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

24060

Intervention / Treatment

Zio XT® Patch

Sponsor

VA Office of Research and Development

Source: clinicaltrials.gov

Share:
Add to list

89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC

Study ID: NCT05423197
Start Date: 2026-06
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

60

Intervention / Treatment

89Zr-panitumumab IV

panitumumab

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Study ID: NCT03429413
Start Date: 2026-09-15
End Date: 2027-09-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1296

Intervention / Treatment

Protect Me 4 Application + External Quality Improvement Support

Protect Me 4 Application Alone

Sponsor

University of Florida

Source: clinicaltrials.gov

Share:
Add to list

Feasibility and Acceptability of Mobile Mental Health App for SZ and SZA

Study ID: NCT06474325
Start Date: 2026-06-01
End Date: 2027-05-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Intervention via mobile application

Sponsor

University of Pittsburgh

Source: clinicaltrials.gov

Share:
Add to list